Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AppHarvest: Value Trap or Buying Opportunity?
AppHarvest: Value Trap or Buying Opportunity?

Looking for investments that genuinely make the world a better place is a great starting point for new investors. Nevertheless, as grand as a company's vision for the future may look, it ultimately

3 Reasons This Tech Platform Will Make Investors Richer
3 Reasons This Tech Platform Will Make Investors Richer

Sales teams have historically relied on experience and intuition to find and land new customers. That's true in just about every industry. But one company is helping them leverage data and

These 3 Dividend ETFs Are a Retiree's Best Friend
These 3 Dividend ETFs Are a Retiree's Best Friend

Dividend ETFs are one of the best investments retirees can make. You need passive income and limited volatility to navigate your golden years, and these vehicles provide both. Dividend income can

Where Are the Best Commercial Real Estate Opportunities Now?
Where Are the Best Commercial Real Estate Opportunities Now?

The real estate market is exceptionally hot right now, but not all areas are seeing the same level of demand. In this Fool Live video clip, recorded on Oct. 1, Fool.com contributor Matt Frankel

3 Top Stocks to Buy in 2021 and Hold for the Next Decade
3 Top Stocks to Buy in 2021 and Hold for the Next Decade

Believe it or not, your calendar has now said goodbye to more than three quarters of 2021. Investors have been treated to twists and turns this year, and volatility has recently been the name of the

Is Nike Ready for the Busy Holiday Season Given Its Supply Chain Issues?
Is Nike Ready for the Busy Holiday Season Given Its Supply Chain Issues?

What might have helped Nike (NYSE: NKE) in good times, such as exposure to fast-growing regions like China, is now hurting the company as it faces supply chain issues worldwide. In this video clip

This Popular App Is Totally Free. Here's Why The Company Might Still Be a Good Investment
This Popular App Is Totally Free. Here's Why The Company Might Still Be a Good Investment

If you want to learn a new language, chances are you'll come across Duolingo's(NASDAQ: DUOL) app. It has been downloaded over 500 million times, is loved by people around the world, and is run by a

This Company Got Hit With a Perfect Storm When the Pandemic Started -- How Are Things Going Now?
This Company Got Hit With a Perfect Storm When the Pandemic Started -- How Are Things Going Now?

Howard Hughes Corporation (NYSE: HHC) is a developer of master-planned communities, and it couldn't have had a worse combination of geographical concentrations when the COVID-19 pandemic hit. The

2 No-Brainer Stocks to Buy With $1,000 Right Now
2 No-Brainer Stocks to Buy With $1,000 Right Now

Investors don't have to take on huge risks to achieve market-beating returns. If you buy stakes in strong companies with sustainable competitive advantages and give those positions some time to

Amazon Believes This Could Be Bigger for Its Business Than Movies
Amazon Believes This Could Be Bigger for Its Business Than Movies

New World is a video game created by Amazon (NASDAQ: AMZN). After being delayed for over a year, it finally launched on Sept. 28. This isn't the first time Amazon's made a video game, but New World

2 Stocks to Buy to Capitalize on Data Transformation
2 Stocks to Buy to Capitalize on Data Transformation

With more data being produced by the day due to the shift to the cloud from on-premise systems, companies around the world are starting to struggle to manage it all and make the most of it. IDC, a

Here's One Recent SPAC IPO That I Can't Get Enough Of
Here's One Recent SPAC IPO That I Can't Get Enough Of

Latch (NASDAQ: LTCH) is one of the more interesting technology companies to go public in the recent boom in special-purpose acquisition companies (SPACs), and some of our experts like what they see

Enrolling in Medicare Advantage for the First Time? 3 Things You Need to Know
Enrolling in Medicare Advantage for the First Time? 3 Things You Need to Know

Medicare's open enrollment period is now in full swing, which means those who are already on Medicare have an opportunity to review their coverage and make changes for 2022. One such change you may

Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?

AstraZeneca (NASDAQ: AZN) awaits U.S. Emergency Use Authorization for its COVID-19 antibody therapy as a prophylaxis. The company also recently announced positive results for the therapy in treating

Building a Stock Portfolio? Here's How to Think About Position Sizing
Building a Stock Portfolio? Here's How to Think About Position Sizing

If you have around 25 stocks in your portfolio, you may be wondering what your average position size should be. In this video clip from "Beat & Raise," recorded on Sept. 24, contributors Brian

Analysts Are Losing Hope in Canopy Growth. Should Investors Ditch the Stock?
Analysts Are Losing Hope in Canopy Growth. Should Investors Ditch the Stock?

Pot stocks haven't made for great investments of late; in just the past six months, the Horizons Marijuana Life Sciences ETF has fallen more than 31%. And cannabis producer Canopy Growth (NASDAQ:

These Stocks Are Shaping the Future of Technology
These Stocks Are Shaping the Future of Technology

As an investor, knowledge of the past can help you understand the future. That may sound counterintuitive, but history tends to repeat itself in subtle ways. For instance, innovative technologies

3 Ways to Effortlessly Boost Retirement Savings Without Downgrading Your Lifestyle
3 Ways to Effortlessly Boost Retirement Savings Without Downgrading Your Lifestyle

For most people, retirement savings is important but investing more for the future can seem impossible. Saving for later can require sacrifice now, and investing for retirement is likely competing

Nike vs. Lululemon: Which Is the Better Buy?
Nike vs. Lululemon: Which Is the Better Buy?

Lululemon (NASDAQ: LULU) is an innovative retailer with a long runway ahead of it, but Nike (NYSE: NKE) is an established leader in the space. In this video clip from "Beat & Raise," recorded on

1 Reason to Sell Latch and 3 Reasons to Buy
1 Reason to Sell Latch and 3 Reasons to Buy

Shares of recent special purpose acquisition company (SPAC) IPO Latch (NASDAQ: LTCH) took a tumble following a downgrade from Goldman Sachs. Due to delays in construction projects and other

Creativity Is Optionality: Why This Stock Should Be Held Forever
Creativity Is Optionality: Why This Stock Should Be Held Forever

Optionality is defined as "the quality of being available to be chosen but not obligatory." When applied to stocks, optionality represents the possible avenues in a company's long-term growth story

Could Viatris Stock Help You Retire a Millionaire?
Could Viatris Stock Help You Retire a Millionaire?

Given that it's one of the world's largest drugmakers, it's reasonable to think that Viatris (NASDAQ: VTRS) could be a reliable wealth building stock. Though the company's generic drugs and

Want $100 in Monthly Dividend Income? Invest $15,100 in These High-Yield Stocks
Want $100 in Monthly Dividend Income? Invest $15,100 in These High-Yield Stocks

There's no one-size-fits-all moneymaking strategy on Wall Street. Over time, we've watched growth and value investors thrive. But if there's been one near-constant, it's the outperformance of

Is Pinterest Waving The White Flag in PayPal Talks?
Is Pinterest Waving The White Flag in PayPal Talks?

Pinterest (NYSE: PINS) shares popped Wednesday on news that the company is in talks with fintech giant PayPal (NASDAQ: PYPL) to be acquired for $70 a share.

Naturally, the stock reacted positively

2 Upcoming FDA Approval Decisions That Investors Should Really Watch
2 Upcoming FDA Approval Decisions That Investors Should Really Watch

Few things are more important to drugmakers than winning regulatory approvals for new products. In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli